362 related articles for article (PubMed ID: 32511987)
21. The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Na
Wright ZVF; McCarthy S; Dickman R; Reyes FE; Sanchez-Martinez S; Cryar A; Kilford I; Hall A; Takle AK; Topf M; Gonen T; Thalassinos K; Tabor AB
J Am Chem Soc; 2017 Sep; 139(37):13063-13075. PubMed ID: 28880078
[TBL] [Abstract][Full Text] [Related]
22. Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.
Henriques ST; Deplazes E; Lawrence N; Cheneval O; Chaousis S; Inserra M; Thongyoo P; King GF; Mark AE; Vetter I; Craik DJ; Schroeder CI
J Biol Chem; 2016 Aug; 291(33):17049-65. PubMed ID: 27311819
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
[TBL] [Abstract][Full Text] [Related]
24. Engineering of highly potent and selective HNTX-III mutant against hNa
Zhang Y; Wang L; Peng D; Zhang Q; Yang Q; Li J; Li D; Tang D; Chen M; Liang S; Liu Y; Wang S; Liu Z
J Biol Chem; 2021; 296():100326. PubMed ID: 33493520
[TBL] [Abstract][Full Text] [Related]
25. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
[TBL] [Abstract][Full Text] [Related]
26. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
Liu Z; Cai T; Zhu Q; Deng M; Li J; Zhou X; Zhang F; Li D; Li J; Liu Y; Hu W; Liang S
J Biol Chem; 2013 Jul; 288(28):20392-403. PubMed ID: 23703613
[TBL] [Abstract][Full Text] [Related]
27. Computational design of peptides to target Na
Nguyen PT; Nguyen HM; Wagner KM; Stewart RG; Singh V; Thapa P; Chen YJ; Lillya MW; Ton AT; Kondo R; Ghetti A; Pennington MW; Hammock B; Griffith TN; Sack JT; Wulff H; Yarov-Yarovoy V
Elife; 2022 Dec; 11():. PubMed ID: 36576241
[TBL] [Abstract][Full Text] [Related]
28. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
[TBL] [Abstract][Full Text] [Related]
29. µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
Zhang YX; Peng DZ; Zhang QF; Huang B; Yang QC; Tang DF; Chen MZ; Rong MQ; Liu ZH
Acta Pharmacol Sin; 2019 Jul; 40(7):859-866. PubMed ID: 30382183
[TBL] [Abstract][Full Text] [Related]
30. Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
Tran HNT; Tran P; Deuis JR; Agwa AJ; Zhang AH; Vetter I; Schroeder CI
Bioconjug Chem; 2020 Jan; 31(1):64-73. PubMed ID: 31790574
[TBL] [Abstract][Full Text] [Related]
31. Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
Xu H; Li T; Rohou A; Arthur CP; Tzakoniati F; Wong E; Estevez A; Kugel C; Franke Y; Chen J; Ciferri C; Hackos DH; Koth CM; Payandeh J
Cell; 2019 Feb; 176(4):702-715.e14. PubMed ID: 30661758
[TBL] [Abstract][Full Text] [Related]
32. A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome.
Cardoso FC; Castro J; Grundy L; Schober G; Garcia-Caraballo S; Zhao T; Herzig V; King GF; Brierley SM; Lewis RJ
Pain; 2021 Feb; 162(2):569-581. PubMed ID: 32826759
[TBL] [Abstract][Full Text] [Related]
33. Potency-Enhancing Mutations of Gating Modifier Toxins for the Voltage-Gated Sodium Channel Na
Katz D; Sindhikara D; DiMattia M; Leffler AE
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800031
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent- and tagged-protoxin II peptides: potent markers of the Na
Montnach J; De Waard S; Nicolas S; Burel S; Osorio N; Zoukimian C; Mantegazza M; Boukaiba R; Béroud R; Partiseti M; Delmas P; Marionneau C; De Waard M
Br J Pharmacol; 2021 Jul; 178(13):2632-2650. PubMed ID: 33742442
[TBL] [Abstract][Full Text] [Related]
35. Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNa
Zhang Y; Yang Q; Zhang Q; Peng D; Chen M; Liang S; Zhou X; Liu Z
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30181499
[TBL] [Abstract][Full Text] [Related]
36. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP
J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998
[TBL] [Abstract][Full Text] [Related]
37. Molecular interactions of the gating modifier toxin ProTx-II with NaV 1.5: implied existence of a novel toxin binding site coupled to activation.
Smith JJ; Cummins TR; Alphy S; Blumenthal KM
J Biol Chem; 2007 Apr; 282(17):12687-97. PubMed ID: 17339321
[TBL] [Abstract][Full Text] [Related]
38. The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.
Rahnama S; Deuis JR; Cardoso FC; Ramanujam V; Lewis RJ; Rash LD; King GF; Vetter I; Mobli M
PLoS One; 2017; 12(3):e0173551. PubMed ID: 28301520
[TBL] [Abstract][Full Text] [Related]
39. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
[TBL] [Abstract][Full Text] [Related]
40. Tarantula toxin ProTx-I differentiates between human T-type voltage-gated Ca2+ Channels Cav3.1 and Cav3.2.
Ohkubo T; Yamazaki J; Kitamura K
J Pharmacol Sci; 2010; 112(4):452-8. PubMed ID: 20351484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
